Daily
250 words
8/10
Rating

17 July 2026

NITI Aayog proposal for BioEconomy Growth Fund

This is a flagship NITI Aayog report proposing a major national policy and a specific financial mechanism (BioEconomy Growth Fund) to drive a critical sector, making it highly likely to be asked in the context of economic growth and S&T development.

1 min read 2 questions 2 prelims

Notes

  • NITI Aayog report: 'Roadmap for building India as a leading bioeconomy powerhouse by 2035'.
  • Goal: Transform India into a top three global biotechnology power by 2035.
  • Economic targets: Expand bioeconomy from $195.3 billion (2025) to $691 billion (2035) and $2.6 trillion (2047).
  • Employment goal: Creation of over 30 million high-value jobs.
  • Proposed BioEconomy Growth Fund: ₹50,000-crore (2026-35) to bridge the 'valley of death' between research and commercial manufacturing.
  • Financial instruments: Blended finance, equity-risk instruments, viability-gap funding, and infrastructure support.
  • Strategy: Move beyond BioE3 policy to mission-mode execution, regulatory reforms, and cross-ministerial governance.
  • Six National BioMissions: GeneIndia (therapies), AgriBio 2.0 (climate-resilient crops), BioX Foundry (synthetic biology), One Health Grid (surveillance), Marine Biotechnology (seaweed/marine products), and BioPharmaNext (biologics/AI-drug discovery).

Questions

  1. Discuss the significance of the proposed 'BioEconomy Growth Fund' in bridging the 'valley of death' for India's biotechnology sector and its role in achieving the vision of a $2.6 trillion bioeconomy by 2047. 150 words
    Attempt this — 150 words in 8 min
    0 / 150 words 8:00
  2. To transform India into a global biotechnology powerhouse, a mission-mode approach is essential. Analyze the role of the proposed National BioMissions in integrating research, manufacturing, and regulatory reforms to enhance India's competitive edge in the global bioeconomy. 250 words
    Attempt this — 250 words in 11 min
    0 / 250 words 11:00

Prelims

  1. The 'valley of death' in the context of the NITI Aayog biotechnology roadmap refers to:

  2. Which of the following is NOT one of the six proposed National BioMissions mentioned in the NITI Aayog roadmap?